Repatha®

I am a healthcare professional

This site is for use in the United Kingdom only. By clicking to enter this site you are confirming that you are a UK Healthcare Professional.

Click here

I am a Repatha® (evolocumab) patient

This site is intended for UK Repatha® patients. By clicking to enter this website you are confirming that you are a patient in the UK who has been prescribed Repatha®

Patient Home

I am a member of the UK public

Click here

REPORTING OF SIDE EFFECTS
Repatha® (evolocumab) is subject to additional monitoring.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Amgen Limited on +44 (0) 1223 436 441.

Registered office: 240 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire, CB4 0WD, United Kingdom.

This website is developed and funded by Amgen® UK. This website is intended for the UK.

This website will not collect any personal or private information. To find out more about Amgen's® privacy practices view the Amgen Privacy Statement.
UKIE-P-145-0716-034566(1)x April 2018